etoposide has been researched along with Esophageal Neoplasms in 86 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (9.30) | 18.7374 |
1990's | 38 (44.19) | 18.2507 |
2000's | 22 (25.58) | 29.6817 |
2010's | 15 (17.44) | 24.3611 |
2020's | 3 (3.49) | 2.80 |
Authors | Studies |
---|---|
Emi, M; Hamai, Y; Hirano, K; Hirohata, R; Ohsawa, M; Okada, M; Yamaguchi, S; Yoshikawa, T | 1 |
Boku, N; Daiko, H; Hirano, H; Honma, Y; Inaba, K; Itami, J; Ito, Y; Iwasa, S; Kanamori, J; Kato, K; Murakami, N; Nagashima, K; Oguma, J; Okita, N; Shoji, H; Takashima, A | 1 |
Endo, M; Fukuda, K; Hasegawa, N; Hattori, J; Hirose, S; Hyodo, I; Ishige, K; Kawai, H; Komatsu, Y; Mizokami, Y; Mizui, T; Nagase, M; Sato, M; Yamamoto, Y; Yamaura, M | 1 |
Feng, R; Jiang, S; Meng, X; Wang, R; Xu, X; Yan, H; Zhu, K | 1 |
Brickman, A; Gallo, K; Gattuso, P; Seder, CW; Warren, WH | 1 |
Arora, S; Baghmar, S; Bhasker, S; Chander, S; Gogia, A; Kumar, R; Nath, D; Sahai, P; Sikka, K | 1 |
Deng, W; Li, N; Luo, S; Shen, W; Wei, C | 1 |
Chen, H; Ding, F; Huang, F; Li, S; Li, Y; Liu, Z; Luo, A; Zhang, W; Zhao, Y | 1 |
Bokhyan, V; Davydov, M; Fedyanin, M; Kononets, P; Malikhova, O; Minin, K; Pokataev, I; Shogenov, M; Stilidi, I; Tjulandin, S; Tryakin, A; Vybarava, A | 1 |
Jeong, HY; Kang, SH; Kim, DK; Kim, MH; Moon, HS; Seong, JK | 1 |
Sun, YK; Wang, JW; Zhan, XK; Zhang, W | 1 |
Drew, PA; Jamieson, GG; Liu, JF; Wu, TC; Zhu, GJ | 1 |
Lv, L; Song, B; Song, X; Wang, X; Wei, L; Xie, L; Yu, J | 1 |
Abe, H; Aizawa, R; Aizawa, Y; Kitahara, T; Kubo, Y; Matsuoka, M; Tajiri, H; Takakura, K; Yoshizawa, K | 1 |
Fujita, H; Matono, S; Murata, K; Nagano, T; Nishimura, K; Shirouzu, K; Tanaka, T; Yamana, H | 1 |
He, J; Song, Y; Wang, JW; Wang, LH; Wu, LY | 1 |
Atsumi, K; Hirata, H; Honda, H; Isoyama, Y; Matsuura, S; Nomoto, S; Nonoshita, T; Ohga, S; Onishi, K; Shioyama, Y; Terashima, K | 1 |
Hiroshima, K; Kawamura, K; Kobayashi, H; Li, Q; Liang, M; Ma, G; Okamoto, S; Shimada, H; Suzuki, N; Tada, Y; Tagawa, M; Tatsumi, K | 1 |
Boonstra, JJ; Dinjens, WN; Kok, TC; Siersema, PD; Ten Kate, FJ; Tilanus, HW; van Berge Henegouwen, MI; van der Gaast, A; van Heijl, M; van Lanschot, JJ; Wijnhoven, BP | 1 |
Adachi, Y; Arimura, Y; Endo, T; Ishii, Y; Sawada, T; Yasui, H | 1 |
Matsunaga, M; Miwa, K; Noguchi, T; Sasaki, Y | 1 |
Du, XH; Mao, WM; Wang, SY; Xu, YP; Zhang, SZ | 1 |
Hagiwara, N; Makino, H; Maruyama, H; Miyashita, M; Nagasawa, S; Nomura, T; Onda, M; Sasajima, K; Tajiri, T; Takubo, K; Tsuchiya, Y; Yamashita, K | 1 |
Aydingöz, U; Ayhan, A; Erman, M; Güler, N; Karaoğlu, A; Oksüzoğlu, B | 1 |
Fujita, S; Kitani, K; Morimoto, T; Nakahira, S; Nomura, T; Okuda, H; Shibata, N; Takeda, M; Tanaka, T; Tsujie, M | 1 |
Huang, J; Jiao, SC; Lu, SX; Sun, Y | 1 |
PROPST, A | 1 |
Brega-Massone, PP; Cataldo, I; Conti, B; Ferro, F; Lequaglie, C | 1 |
Richter, P; Solecki, R; Szura, M; Zajac, A | 1 |
Albregts, M; Crezee, H; Fockens, P; González González, D; Hulshof, MC; Richel, DJ; van Dijk, JD; van Lanschot, JJ; Zum Vörde Sive Vörding, PJ | 1 |
Ishida, Y; Udagawa, I; Watanabe, S | 1 |
Budach, W; Franke, C; Klump, B; Lehmann, N; Meyer, HJ; Schmitt, G; Schmitt, M; Seeber, S; Stahl, M; Stuschke, M; Teichmann, R; Walz, MK; Wilke, H | 1 |
Fujikaw, K; Kato, J; Niitsu, Y; Nishiie, K; Okubo, S; Sato, Y; Shintani, N; Takada, K; Takahashi, Y; Takimoto, R | 1 |
Hejna, M; Raderer, M | 1 |
Hashimoto, T; Izumi, Y; Kato, T; Kawada, K; Miura, A; Momma, K; Oota, M | 1 |
Chen, A; Ding, F; Liu, Z; Luo, A; Ren, S; Yu, Z; Zhang, L; Zhang, S | 1 |
Gotoh, M; Katsu, K; Kawabe, S; Kii, T; Kuwakado, S; Nishitani, H; Ohta, S; Takiuchi, H; Tanaka, T | 1 |
Kelsen, D | 1 |
Bains, M; Coonley, CJ; Dukeman, M; Heelan, R; Kelsen, DP | 1 |
Cvitkovic, E; Golbey, RB; Kelsen, DP; Kurtz, R; Lieberman, P; Weston, E | 1 |
Hamblin, T; Loehry, CA; McCullen, M; Parham, DM; Vyas, SK; Winwood, PJ | 1 |
Kok, T; Nooter, K; Smits, HL; ter Schegget, J; Tjong-A-Hung, SP | 1 |
Aizawa, K; Hatakeyama, K; Muto, I; Nishimaki, T; Suzuki, S; Suzuki, T; Tanaka, N; Tanaka, O; Yabusaki, H | 1 |
Hosomura, Y; Izumi, M; Joshita, T; Kawashima, Y; Kobayashi, I; Lino, Y; Morishita, Y; Nakamura, S; Ogawa, T; Ohwada, S | 1 |
Hordijk, ML; Kok, TC; Mulder, AH; Wilson, JH | 1 |
Ajani, J; David, C; DuBrow, R; Fornage, B; Levin, B; Lynch, P; Roth, J; Roubein, LD | 1 |
Achterrath, W; Berger, M; Berns, T; Fink, U; Harstrick, A; Knipp, H; Meyer, HJ; Preusser, P; Stahl, M; Wilke, H | 1 |
Boku, N; Fujii, T; Koba, I; Miyata, Y; Muro, K; Oda, Y; Ohnaka, O; Ohtsu, A; Shimizu, W; Yoshida, S | 1 |
Adelstein, DJ; Boyce, GA; Bukowski, RM; Kirby, TJ; Rice, TW; Sivak, MV; Van Kirk, MA; van Stolk, RU | 1 |
Adkins, RB; Hoff, SJ; Johnson, DH; Merrill, WH; Murray, MJ; Sawyers, JL; Stewart, JR | 1 |
Matsumoto, M; Nakae, J; Nishikawa, H; Nomiyama, T | 1 |
Ajani, JA; Gutterman, JU; Levin, B; McMurtrey, M; Pazdur, R; Putnam, JB; Roth, JA; Ryan, MB | 1 |
Breuer, N; Eigler, FW; Fett, W; Fink, U; Makoski, HB; Molls, M; Niebel, W; Sack, H; Schmidt, U; Seeber, S; Siewert, JR; Stahl, M; Stuschke, M; Walz, MK; Wilke, H | 1 |
Kanazawa, M; Kumegawa, H; Mori, S; Morinaga, K; Tanaka, T | 1 |
Dees, J; Eykenboom, WM; Kok, TC; Splinter, TA; Stoter, G; Tilanus, HW; Van der Gaast, A; Van Overhagen, H | 1 |
Hejna, M; Kornek, GV; Raderer, M; Rosen, H; Scheithauer, W; Schiessel, R; Schoder, M; Schratter-Sehn, AU; Zach, M | 1 |
Cho, CC; Gray, DJ; Jones, JJ; Laufman, LR; Spiridonidis, CH; Young, DC | 1 |
Boardman, P; Braybrooke, JP; Ganesan, TS; Harris, AL; O'Byrne, KJ; Propper, DJ; Salisbury, AJ; Saunders, MP; Talbot, DC; Taylor, M | 1 |
Doi, T; Mandai, K; Nishikawa, Y; Ohmura, Y; Takiyama, W | 1 |
Irwin, JF; Poussin-Rosillo, H; Sardi, A; Waterfield, W | 1 |
Camoriano, JK; Fitch, TR; Frytak, S; Rajkumar, SV; Rubin, J | 1 |
Hihara, J; Hirai, T; Inoue, H; Kuwahara, M; Mukaida, H; Toge, T; Yamashita, Y; Yoshida, K | 1 |
Bosman, FT; Kok, T; Nooter, K; Stoter, G; van Wingerden, KE | 1 |
Müller, C; Stahl, M; Stuschke, M; Vanhoefer, U; Walz, MK; Wilke, H | 1 |
Goya, T; Koshiishi, Y; Miya, T; Nogami, H; Sasaki, Y; Yanagida, O | 1 |
Bellec, V; Blanchi, A; Dugay, J; Foulet, A; Renou, P; Saad, R | 1 |
Asano, T; Gunji, Y; Isono, K; Kimura, M; Koide, Y; Matsubara, H; Ochiai, T; Sakiyama, S; Sugaya, M; Tagawa, M; Takegana, K | 1 |
Anderson, NR; Bern, MM; Coco, FV; Dow, E; Lokich, JJ; Oliynyk, P; Sonneborn, H | 1 |
Hanai, H; Ishibashi, R; Kaneko, E; Osawa, S; Otake, T; Shirai, T; Suzuki, H; Takashima, M; Takayanagi, S | 1 |
Hada, T; Kobayashi, I; Kohno, S; Matai, K; Oda, Y; Ohmori, H; Sasaya, K; Yamazaki, Y | 1 |
Abe, T; Hayashi, H; Hazama, S; Hirose, K; Iizuka, N; Noma, T; Oka, M; Tangoku, A; Yamamoto, K | 1 |
Nortier, JW; Shamelian, SO | 1 |
Oldenburg, A; Sack, H; Seeber, S; Stahl, M; Stüben, G; Stuschke, M; Walz, M; Wilke, H | 1 |
Kok, TC; Polee, MB; Siersema, PD; Splinter, TA; Stoter, G; Tilanus, HW; Van der Gaast, A | 1 |
Bosset, JF; Egreteau, J; Madroszyk, A; Martin, L; Merrouche, Y; Queneau, PE | 1 |
Hikita, M; Kobayashi, M; Kohno, K; Saito, T; Sato, S; Takano, H | 1 |
Roth, JA | 1 |
Bokemeyer, C; Harstrick, A; Knipp, H; Köhne-Wömpner, CH; Meyer, HJ; Preusser, P; Schmoll, HJ; Stahl, M; Wilke, H | 1 |
Adelstein, DJ; Boyce, GA; Kirby, TJ; Rice, TW; Sivak, MV | 1 |
Ando, T; Hao, K; Miyashita, M; Onda, M; Sasajima, K; Takubo, K; Watanabe, M; Yamashita, K | 1 |
Benedetto, P; Feun, LG; Hussein, AM; Otrakji, CL; Sridhar, KS; Waldman, S | 1 |
Abbruzzese, JL; Ajani, JA; DeCaro, L; Jackson, DE; Levin, B; McMurtrey, M; Mountain, C; Rich, TA; Roth, JA; Ryan, B | 1 |
Kelsen, DP; Nichols, GL | 1 |
Kajisa, T; Shimazu, H; Tanabe, G; Yoshida, A | 1 |
Kok, TC; Splinter, TA; Verweij, J | 1 |
Barreras, L; Manten, H; Saldana, MJ; Sridhar, KS | 1 |
8 review(s) available for etoposide and Esophageal Neoplasms
Article | Year |
---|---|
Carboplatin and etoposide combined with radiotherapy for limited-stage small-cell esophageal carcinoma: three cases and review of the literature.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Esophageal Neoplasms; Etoposide; Female; Humans; Male; Middle Aged; Radiation Injuries | 2010 |
[A patient with stage IVb small cell carcinoma of the esophagus who survived 23 months after systemic cancer chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Esophageal Neoplasms; Etoposide; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Staging; Survivors | 2003 |
[A case of granulocyte-colony stimulating factor producing small cell carcinoma of esophagus].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Drug Administration Schedule; Esophageal Neoplasms; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Male; Remission Induction | 2005 |
[Neoadjuvant therapy for resectable esophageal cancer].
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Dose Fractionation, Radiation; Esophageal Neoplasms; Etoposide; Fluorouracil; Humans; Meta-Analysis as Topic; Neoadjuvant Therapy; Postoperative Care; Preoperative Care; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Time Factors; Vindesine | 2005 |
Chemotherapy of esophageal cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Doxorubicin; Esophageal Neoplasms; Etoposide; Fluorouracil; Humans; Lomustine; Methotrexate; Mitoguazone; Mitomycin; Mitomycins; Neoplasm Metastasis; Postoperative Care; Preoperative Care; Vinblastine; Vindesine | 1984 |
Small cell carcinoma of the esophagus: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Small Cell; Cisplatin; Disease-Free Survival; Esophageal Neoplasms; Esophagoscopy; Esophagus; Etoposide; Humans; Male; Middle Aged; Tomography, X-Ray Computed | 1997 |
Small-cell carcinoma of the esophagus: report of three cases and review of the literature with emphasis on therapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Esophageal Neoplasms; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Retrospective Studies; Treatment Outcome | 2001 |
Combination chemotherapy and radiotherapy for small-cell carcinoma of the esophagus. A case report of long-term survival and review of the literature.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Esophageal Neoplasms; Etoposide; Female; Humans; Prognosis; Remission Induction; Vincristine | 1990 |
21 trial(s) available for etoposide and Esophageal Neoplasms
Article | Year |
---|---|
Preoperative chemotherapy in patients with resectable esophageal carcinoma: a single center Phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Prospective Studies | 2016 |
A preliminary study on the postoperative survival of patients given aspirin after resection for squamous cell carcinoma of the esophagus or adenocarcinoma of the cardia.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Aspirin; Carcinoma, Squamous Cell; Cardia; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclooxygenase 2 Inhibitors; Esophageal Neoplasms; Esophagectomy; Etoposide; Female; Fluorouracil; Gastrectomy; Humans; Male; Middle Aged; Radiotherapy, Adjuvant; Stomach Neoplasms; Survival Analysis | 2009 |
Chemotherapy followed by surgery versus surgery alone in patients with resectable oesophageal squamous cell carcinoma: long-term results of a randomized controlled trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Etoposide; Female; Humans; Male; Middle Aged; Survival Analysis; Treatment Outcome | 2011 |
A feasibility study in oesophageal carcinoma using deep loco-regional hyperthermia combined with concurrent chemotherapy followed by surgery.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Etoposide; Feasibility Studies; Female; Humans; Hyperthermia, Induced; Male; Middle Aged; Neoplasm Staging; Patient Selection; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Survival Analysis | 2005 |
Neoadjuvant chemotherapy with etoposide, leucovorin, 5-fluorouracil and cisplatin for advanced esophageal squamous cell carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Esophageal Neoplasms; Esophagectomy; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Lymphatic Metastasis; Male; Middle Aged; Pilot Projects; Survival Rate | 1995 |
5-Fluorouracil, folinic acid, etoposide and cisplatin chemotherapy for locally advanced or metastatic carcinoma of the oesophagus.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Esophageal Neoplasms; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Leukopenia; Male; Middle Aged; Remission Induction; Thrombocytopenia; Treatment Outcome | 1994 |
Adenocarcinoma of the esophagus and gastroesophageal junction. Clinical and pathologic assessment of response to induction chemotherapy.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Esophageal Neoplasms; Esophagogastric Junction; Etoposide; Humans; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Remission Induction; Survival Analysis; Treatment Outcome | 1994 |
Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer. Interim analysis of a phase II trial.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Squamous Cell; Cause of Death; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Male; Preoperative Care; Survival Analysis; Treatment Failure | 1996 |
Cisplatin and etoposide in oesophageal cancer: a phase II study. Rotterdam Oesophageal Tumour Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Esophageal Neoplasms; Etoposide; Female; Humans; Male; Middle Aged; Survival Rate | 1996 |
Effective radiochemotherapy with cisplatin and etoposide for the management of patients with locally inoperable and metastatic esophageal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Staging; Prognosis | 1996 |
A phase II evaluation of high dose cisplatin and etoposide in patients with advanced esophageal adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Esophageal Neoplasms; Etoposide; Female; Humans; Male; Middle Aged; Palliative Care; Survival Rate | 1996 |
A phase II study of mitomycin C and oral etoposide for advanced adenocarcinoma of the upper gastrointestinal tract.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Esophageal Neoplasms; Etoposide; Female; Humans; Injections, Intravenous; Male; Middle Aged; Mitomycin; Stomach Neoplasms; Treatment Outcome | 1997 |
Combination chemotherapy with cisplatin, carboplatin, and etoposide in advanced malignancy: a phase I trial.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cause of Death; Cisplatin; Clinical Trials, Phase II as Topic; Cochlea; Digestive System Neoplasms; Drug Administration Schedule; Drug Synergism; Esophageal Neoplasms; Etoposide; Evaluation Studies as Topic; Female; Humans; Kidney; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nausea; Neutropenia; Remission Induction; Sepsis; Stomach Neoplasms; Thrombocytopenia; Vomiting | 1997 |
Clinical evaluation of adjuvant chemoradiotherapy with CDDP, 5-FU, and VP-16 for advanced esophageal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Esophageal Neoplasms; Etoposide; Female; Fluorouracil; Humans; Male; Middle Aged; Prognosis; Survival Rate | 1998 |
Expression of the multidrug resistance protein (MRP) in squamous cell carcinoma of the oesophagus and response to pre-operative chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP-Binding Cassette Transporters; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Esophageal Neoplasms; Etoposide; Female; Genes, MDR; Humans; Immunohistochemistry; Male; Middle Aged; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Preoperative Care; Prospective Studies; RNA, Messenger | 1998 |
The influence of relative body weight on toxicity of combination chemotherapy with cisplatin and etoposide.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Body Surface Area; Body Weight; Carcinoma, Non-Small-Cell Lung; Cisplatin; Creatinine; Esophageal Neoplasms; Etoposide; Female; Hematologic Tests; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Sex Factors; Thrombocytopenia | 1998 |
Combined paclitaxel, cisplatin, and etoposide for patients with previously untreated esophageal and gastroesophageal carcinomas.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Esophageal Neoplasms; Esophagogastric Junction; Etoposide; Female; Humans; Male; Middle Aged; Paclitaxel; Stomach Neoplasms; Survival Rate; Treatment Outcome | 1999 |
Phase II study of the combination cisplatin, etoposide, 5-fluorouracil and folinic acid in patients with advanced squamous cell carcinoma of the esophagus.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Esophageal Neoplasms; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged | 2001 |
[Squamous cell cancer of the esophagus. Treatment concept at the Houston M.D. Anderson Cancer Center].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cancer Care Facilities; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Esophageal Neoplasms; Etoposide; Fluorouracil; Humans; Neoplasm Staging; Prospective Studies; Texas | 1992 |
Phase II study of single-agent etoposide in patients with metastatic squamous-cell carcinoma of the esophagus.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Drug Evaluation; Esophageal Neoplasms; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Remission Induction; Time Factors | 1992 |
57 other study(ies) available for etoposide and Esophageal Neoplasms
Article | Year |
---|---|
Esophageal Neuroendocrine Carcinoma With Pathological Complete Response After Neoadjuvant Chemotherapy Followed by Robot-assisted Surgery: A Case Report.
Topics: Aged; Carboplatin; Carcinoma, Neuroendocrine; Esophageal Neoplasms; Etoposide; Female; Humans; Neoadjuvant Therapy; Robotic Surgical Procedures | 2023 |
Clinical outcomes of locally advanced esophageal neuroendocrine carcinoma treated with chemoradiotherapy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Chemoradiotherapy; Cisplatin; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Prognosis; Retrospective Studies; Survival Rate | 2020 |
Mediastinal Neuroendocrine Carcinoma Slowly Growing for 8 Years after Surgical Resection of Esophageal Squamous Cell Carcinoma.
Topics: Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Neuroendocrine; Cisplatin; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Etoposide; Female; Humans; Lymph Nodes; Mediastinal Neoplasms; Neoplasm Recurrence, Local; Radiotherapy; Treatment Outcome | 2020 |
NSE can predict the sensitivity to definitive chemoradiotherapy of small cell carcinoma of esophagus.
Topics: Aged; Antigens, Neoplasm; Biomarkers, Tumor; Carcinoembryonic Antigen; Carcinoma, Small Cell; Chemoradiotherapy; Cisplatin; Endosonography; Esophageal Neoplasms; Etoposide; Female; Humans; Keratin-19; Lymphatic Metastasis; Male; Middle Aged; Phosphopyruvate Hydratase; Positron-Emission Tomography; Predictive Value of Tests; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Unresectable Middle Mediastinal Biphasic Pulmonary Blastoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Esophageal Neoplasms; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Male; Mediastinal Neoplasms; Neoplasm Staging; Neoplasms, Multiple Primary; Prognosis; Pulmonary Blastoma; Testicular Neoplasms | 2015 |
Extrapulmonary Small Cell Carcinoma - a Case Series of Oropharyngeal and Esophageal Primary Sites Treated with Chemo-Radiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Esophageal Neoplasms; Etoposide; Female; Humans; Male; Middle Aged; Neoadjuvant Therapy; Oropharyngeal Neoplasms; Palliative Care | 2015 |
[Prognostic impact of different chemotherapy strategies on small cell esophageal carcinoma].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Chi-Square Distribution; Cisplatin; Esophageal Neoplasms; Etoposide; Humans; Multivariate Analysis; Prognosis; Proportional Hazards Models; Retrospective Studies; Survival Rate; Treatment Outcome | 2015 |
Inhibitor of Differentiation/DNA Binding 1 (ID1) Inhibits Etoposide-induced Apoptosis in a c-Jun/c-Fos-dependent Manner.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Binding Sites; Carcinoma, Squamous Cell; Caspase 3; Cell Line, Tumor; Cell Proliferation; DNA Damage; DNA, Neoplasm; Drug Resistance, Neoplasm; Esophageal Neoplasms; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Differentiation Protein 1; JNK Mitogen-Activated Protein Kinases; Poly(ADP-ribose) Polymerases; Promoter Regions, Genetic; Protein Binding; Proto-Oncogene Proteins c-fos; RNA, Small Interfering; Signal Transduction; Survival Analysis; Transcription Factor AP-1 | 2016 |
A Case of Endoscopically Complete Remission of Esophageal Neuroendocrine Tumors by Concurrent Chemoradiation Therapy.
Topics: Carcinoembryonic Antigen; Carcinoma, Neuroendocrine; Chemoradiotherapy; Chromogranin A; Cisplatin; Esophageal Neoplasms; Esophagoscopy; Etoposide; Female; Humans; Liver Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography; Synaptophysin | 2016 |
[Clinical analysis of 81 cases with primary small cell carcinoma of the esophagus].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Esophageal Neoplasms; Esophagectomy; Etoposide; Female; Follow-Up Studies; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neoplastic Cells, Circulating; Proportional Hazards Models; Retrospective Studies; Survival Rate | 2008 |
Fractionated irradiation induced radio-resistant esophageal cancer EC109 cells seem to be more sensitive to chemotherapeutic drugs.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cisplatin; Dose Fractionation, Radiation; Doxorubicin; Drug Resistance, Neoplasm; Esophageal Neoplasms; Etoposide; Fluorouracil; Humans; Paclitaxel; Radiation Tolerance; Tumor Cells, Cultured; X-Rays | 2009 |
[A case of primary small cell carcinoma of the esophagus responding remarkably to carboplatin (CBDCA) + etoposide (VP-16) combination therapy and radiation therapy].
Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Esophageal Neoplasms; Etoposide; Humans; Male | 2009 |
Surgical management for small cell carcinoma of the esophagus.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Esophagectomy; Etoposide; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Retrospective Studies; Treatment Outcome | 2010 |
[Treatment and prognosis of extrapulmonary small cell carcinoma of 243 cases].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Esophageal Neoplasms; Etoposide; Female; Follow-Up Studies; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Radiotherapy, High-Energy; Survival Rate; Urogenital Neoplasms; Young Adult | 2010 |
Combinatory cytotoxic effects produced by E1B-55kDa-deleted adenoviruses and chemotherapeutic agents are dependent on the agents in esophageal carcinoma.
Topics: Adenoviridae; Adenovirus E1B Proteins; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cisplatin; Esophageal Neoplasms; Etoposide; Female; Fluorouracil; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Mitomycin; Oncolytic Virotherapy; Virus Replication | 2010 |
Esophageal lesions in myeloproliferative neoplasms.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Esophageal Neoplasms; Etoposide; Humans; Male; Myeloproliferative Disorders; Prednisolone; Ulcer | 2012 |
Small cell carcinoma of gastro-oesophageal junction with remarkable response to chemo-radiotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Chemoradiotherapy, Adjuvant; Cisplatin; Esophageal Neoplasms; Esophagogastric Junction; Etoposide; Humans; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Remission Induction; Stomach Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
The 2002 AJCC TNM classification is a better predictor of primary small cell esophageal carcinoma outcome than the VALSG staging system.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Esophagectomy; Etoposide; Female; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Radiotherapy, High-Energy; Retrospective Studies; Societies, Medical; Survival Rate; United States | 2013 |
Effectiveness of preoperative chemotherapy using carboplatin (CBDCA) and surgery against an esophageal small cell carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carboplatin; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Esophageal Neoplasms; Esophagectomy; Esophagoscopy; Etoposide; Follow-Up Studies; Humans; Immunohistochemistry; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Preoperative Care; Tomography, X-Ray Computed; Treatment Outcome | 2002 |
Solitary esophageal metastasis of breast cancer after 11 years: a case report.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cisplatin; Deglutition Disorders; Diagnosis, Differential; Doxorubicin; Esophageal Neoplasms; Etoposide; Female; Humans; Immunohistochemistry; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Radiography; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 2002 |
[The effect of insulin on chemotherapeutic drug sensitivity in human esophageal and lung cancer cells].
Topics: Adenocarcinoma; Antineoplastic Agents; Cisplatin; Drug Interactions; Esophageal Neoplasms; Etoposide; Fluorouracil; Humans; Insulin; Lung Neoplasms; Tumor Cells, Cultured | 2003 |
[Morphological findings after moving beam irradiation of esophagus carcinoma].
Topics: Carcinoma; Carmustine; Esophageal Neoplasms; Etoposide; Humans; Radiotherapy | 1957 |
[The role of surgical therapy for esophageal microcytoma. Experience of there clinical cases and results analysis].
Topics: Aged; Anastomosis, Surgical; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Esophageal Neoplasms; Esophagectomy; Esophagoplasty; Esophagoscopy; Etoposide; Fatal Outcome; Female; Humans; Laparotomy; Lymph Node Excision; Male; Middle Aged; Mitomycin; Remission Induction; Stomach; Thoracotomy; Vinblastine; Vinorelbine | 2003 |
Bifocal esophageal and rectal cancer palliatively treated with argon plasma coagulation.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Argon; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease Progression; Doxorubicin; Esophageal Neoplasms; Etoposide; Fatal Outcome; Humans; Light Coagulation; Male; Microsurgery; Neoplasms, Second Primary; Palliative Care; Rectal Neoplasms | 2004 |
[A case report of esophageal small cell carcinoma: a long-term survival by radio-chemotherapy with carboplatin and etoposide].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Drug Administration Schedule; Esophageal Neoplasms; Etoposide; Humans; Male; Middle Aged; Radiotherapy, High-Energy; Remission Induction; Survivors | 2004 |
[Superficial small cell carcinoma of esophagus treated by endoscopic mucosal resection combined with chemoradiotherapy--a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Esophageal Neoplasms; Esophagectomy; Esophagoscopes; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Irinotecan; Mucous Membrane | 2007 |
XIAP is highly expressed in esophageal cancer and its downregulation by RNAi sensitizes esophageal carcinoma cell lines to chemotherapeutics.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cell Line, Tumor; Cisplatin; Esophageal Neoplasms; Etoposide; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Paclitaxel; RNA Interference; X-Linked Inhibitor of Apoptosis Protein | 2007 |
Evaluation of prognostic factors of esophageal squamous cell carcinoma (stage II-III) after concurrent chemoradiotherapy using biopsy specimens.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Squamous Cell; Combined Modality Therapy; Cyclin D1; Cyclophosphamide; Doxorubicin; ErbB Receptors; Esophageal Neoplasms; Etoposide; Female; Fluorouracil; Humans; Male; Prognosis; Proliferating Cell Nuclear Antigen; Tumor Suppressor Protein p53 | 2007 |
Phase II study of etoposide in the treatment of esophageal carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Drug Evaluation; Esophageal Neoplasms; Etoposide; Humans; Middle Aged; Podophyllotoxin | 1983 |
Small-cell carcinoma of the esophagus: treatment by chemotherapy alone.
Topics: Aged; Antineoplastic Agents; Carcinoma; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Esophageal Neoplasms; Etoposide; Female; Humans; Radiography | 1980 |
Long-term survival associated with metastatic small cell carcinoma of the esophagus treated by chemotherapy, autologous bone marrow transplantation, and adjuvant radiation therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Esophageal Neoplasms; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Liver Neoplasms; Lymphatic Metastasis; Melphalan; Prognosis; Radiotherapy Dosage; Transplantation, Autologous; Vincristine | 1994 |
Absence of human papillomavirus DNA from esophageal carcinoma as determined by multiple broad spectrum polymerase chain reactions.
Topics: Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; DNA Primers; DNA, Viral; Esophageal Neoplasms; Esophagus; Etoposide; Humans; Molecular Sequence Data; Papillomaviridae; Polymerase Chain Reaction | 1995 |
Chemotherapy of human small-cell gastrointestinal carcinoma xenografts in nude mice.
Topics: Aged; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Esophageal Neoplasms; Etoposide; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Mitomycin; Neoplasm Transplantation; Phosphopyruvate Hydratase; Remission Induction; Stomach Neoplasms; Transplantation, Heterologous | 1995 |
Assessment of response of esophageal carcinoma to induction chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Esophageal Neoplasms; Esophagus; Etoposide; Female; Humans; Male; Middle Aged; Prospective Studies; Tomography, X-Ray Computed; Ultrasonography | 1993 |
Endoscopic ultrasonography in the quantitative assessment of response to chemotherapy in patients with adenocarcinoma of the esophagus and esophagogastric junction.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Barium Sulfate; Cisplatin; Doxorubicin; Esophageal Neoplasms; Esophagogastric Junction; Esophagus; Etoposide; Humans; Radiography; Ultrasonography | 1993 |
Small cell carcinoma of the esophagus with an esophago-mediastinal fistula successfully treated by chemoradiation therapy and intubation: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cobalt Radioisotopes; Combined Modality Therapy; Esophageal Fistula; Esophageal Neoplasms; Etoposide; Fistula; Fluorouracil; Humans; Intubation; Lymphatic Metastasis; Male; Mediastinal Diseases; Middle Aged; Radiotherapy Dosage | 1993 |
Preliminary results with neoadjuvant therapy and resection for esophageal carcinoma.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Esophageal Neoplasms; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Male; Postoperative Complications; Prospective Studies; Radiotherapy Dosage; Survival Rate | 1993 |
Combination chemotherapy for a senile patient with adenoid cystic carcinoma of the esophagus: a case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenoid Cystic; Esophageal Neoplasms; Esophagoscopy; Esophagus; Etoposide; Female; Humans; Liver Neoplasms; Tegafur; Tomography, X-Ray Computed | 1993 |
Intensive preoperative chemotherapy with colony-stimulating factor for resectable adenocarcinoma of the esophagus or gastroesophageal junction.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Drug Administration Schedule; Esophageal Neoplasms; Esophagogastric Junction; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Male; Middle Aged; Survival Analysis; Treatment Outcome | 1993 |
[A case report of small cell carcinoma of the esophagus with remarkable response to neoadjuvant chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Esophageal Neoplasms; Esophagectomy; Etoposide; Fluorouracil; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged | 1996 |
Multimodality treatment in the management of esophageal cancer: neoadjuvant chemoradiotherapy followed by transhiatal esophagectomy.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Esophagectomy; Etoposide; Female; Fluorouracil; Humans; Male; Middle Aged; Radiotherapy, Adjuvant; Treatment Outcome | 1997 |
Pre-operative sequential chemo- and radiochemotherapy in locally advanced carcinomas of the lower oesophagus and gastro-oesophageal junction.
Topics: Adenocarcinoma; Aged; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Esophagogastric Junction; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Male; Middle Aged; Preoperative Care; Survival Analysis; Treatment Outcome | 1998 |
[Association of celiac disease and esophageal small cell carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Celiac Disease; Cisplatin; Clinical Protocols; Esophageal Neoplasms; Etoposide; Humans; Male; Middle Aged; Remission Induction | 1999 |
Expression of wild-type p53 gene confers increased sensitivity to radiation and chemotherapeutic agents in human esophageal carcinoma cells.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carcinoma; Cell Division; Cisplatin; Esophageal Neoplasms; Etoposide; Female; Gene Expression Regulation, Neoplastic; Genes, p53; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Microbial Sensitivity Tests; Mutation; Neoplasm Transplantation; Radiation Tolerance; Retroviridae; Transduction, Genetic; Tumor Suppressor Protein p53 | 1999 |
Primary small cell carcinoma of the esophagus with achalasia in a patient in whom pro-gastrin-releasing peptide and neuron-specific enolase levels reflected the clinical course during chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Esophageal Achalasia; Esophageal Neoplasms; Esophagoscopy; Etoposide; Humans; Male; Middle Aged; Peptide Fragments; Peptides; Phosphopyruvate Hydratase; Prognosis; Recombinant Proteins; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 1999 |
[Usefulness of combination therapy with expandable metallic stent replacement and FLEP chemotherapy (consisting of 5-FU, leucovorin, etoposide and cisplatin) for advanced esophageal cancer invading the bronchus: a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Esophageal Neoplasms; Etoposide; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Invasiveness; Stents | 1999 |
The nm23-H1 gene as a predictor of sensitivity to chemotherapeutic agents in oesophageal squamous cell carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Disease-Free Survival; DNA, Complementary; Drug Resistance, Neoplasm; Esophageal Neoplasms; Etoposide; Female; Fluorouracil; Humans; Male; Middle Aged; Monomeric GTP-Binding Proteins; Neoplasm Proteins; NM23 Nucleoside Diphosphate Kinases; Nucleoside-Diphosphate Kinase; Oligonucleotides, Antisense; Survival Analysis; Survival Rate; Transcription Factors; Transfection; Treatment Outcome; Tumor Cells, Cultured | 1999 |
Extrapulmonary small-cell carcinoma: report of three cases and update of therapy and prognosis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Esophageal Neoplasms; Etoposide; Humans; Male; Middle Aged; Pancreatic Neoplasms; Prognosis; Prostatic Neoplasms; Radiotherapy, Adjuvant | 2000 |
Induction chemotherapy followed by concurrent chemotherapy and high-dose radiotherapy for locally advanced squamous cell carcinoma of the upper-thoracic and midthoracic esophagus.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma, Squamous Cell; Cisplatin; Cohort Studies; Combined Modality Therapy; Deglutition Disorders; Drug Administration Schedule; Esophageal Neoplasms; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Prognosis; Quality of Life; Survival Analysis | 2000 |
Different sensitivities of human esophageal cancer cells to multiple anti-cancer agents and related mechanisms.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Northern; Blotting, Western; Carcinoma, Squamous Cell; DNA Topoisomerases, Type II; Drug Resistance; Esophageal Neoplasms; Etoposide; Gene Expression; Glutathione Transferase; Humans; Membrane Glycoproteins; RNA, Neoplasm; Tumor Cells, Cultured; Tumor Stem Cell Assay; Vincristine; Vindesine | 1992 |
Esophageal carcinoma: esophageal ultrasound assessment of preoperative chemotherapy.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Doxorubicin; Esophageal Neoplasms; Esophagoscopy; Esophagus; Etoposide; Humans; Male; Middle Aged; Ultrasonography | 1992 |
Serum neuron-specific enolase as a marker of small-cell carcinoma of the esophagus.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Brain Neoplasms; Carcinoma, Small Cell; Cisplatin; Esophageal Neoplasms; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Phosphopyruvate Hydratase; Skin Neoplasms; Vincristine | 1990 |
Evaluation of pre- and postoperative chemotherapy for resectable adenocarcinoma of the esophagus or gastroesophageal junction.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Esophagogastric Junction; Etoposide; Female; Fluorouracil; Humans; Male; Middle Aged; Survival Analysis; Time Factors | 1990 |
Small cell carcinoma of the esophagus. The Memorial Hospital experience 1970 to 1987.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Evaluation; Esophageal Neoplasms; Etoposide; Female; Humans; Male; Prognosis; Vincristine | 1989 |
Effective chemotherapy for small cell carcinoma of the esophagus.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Doxorubicin; Esophageal Neoplasms; Etoposide; Humans; Male; Vincristine | 1987 |
Etoposide and cisplatin in advanced esophageal cancer. A preliminary report.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Esophageal Neoplasms; Etoposide; Female; Humans; Male; Middle Aged | 1988 |
Respiratory tract fistulae in recurrent aerodigestive cancers after chemotherapy.
Topics: Bronchial Fistula; Carcinoma, Squamous Cell; Cisplatin; Esophageal Neoplasms; Etoposide; Fluorouracil; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Radiography | 1988 |